Skip to main content
AmigoFish

STEM-Talk

Dawn Kernagis and Ken FordAudio

Format:
Podcast
New episodes:
Monthly
Typical length:
about 1 hour 20 minutes
Latest episode:
Not rated yet

About this show

The most interesting people in the world of science and technology

Show details and episodes come from the publisher's public feed at ihmc.us. Last updated . Names, artwork and text belong to their publishers.

Cosmos

Similar by topic and creator

See the full Cosmos

Similar shows

See all Health shows

Explore more

Episodes

  • Episode 200: From rogue AI agents to factchecking AI, Ken Ford responds to more listener AI questions

    · 1 hr 37 min

    Episode 200: From rogue AI agents to factchecking AI, Ken Ford responds to more listener AI questions In today’s third of a three-part series of Ask Me Anything episodes, Dr. Ken Ford responds to more listener questions and concerns about artificial intelligence. In AMA episode 198, Ken answered a wide-range of questions about chatbots and data centers and the future of AI, which prompted a new round of listener questions about AI that Ken will be answering today. Ken has been working in AI since the 1980s and is well-positioned to help listeners sort genuine advances in AI from exaggerated claims. The Association for the Advancement of Artificial Intelligence elected Ford a Fellow in 2000 for his “leadership in exploring and explaining foundational issues and in establishing large-scale AI research programs and institutions.” In today’s episode, Ken tackles listener questions about: — A team leader at Anthropic, the developer of the chatbot Claude, who shared a post that someday “AI could kill all humans.” — the Hugging Face incident in July where OpenAI’s AI agents, operating in a testing environment, broke out, got online, and compromised parts of Hugging Face’s systems. — How to factcheck AI systems that confabulate nonexistent facts. — And that’s just for starters. If you have questions for Ken and Dawn after listening to today’s episode, or any episode of STEM-Talk, email your questions to STEM-Talk producer Randy Hammer at rhammer@ihmc.org. (http://rhammer@ihmc.org) Show notes: [00:04:55] Dawn opens the AMA with a listener question about Evan Hubinger, a team lead at Anthropic who shared his thoughts in a post that someday “AI could kill all humans.” Anthropic is the developer of the chatbot Claude. Hubinger went on to say in his post, which has been viewed tens of millions of times, that he believes there’s more than a 10 percent chance that AI could wipe out humanity within the next decade. The listener asks if we should indeed be terrified that AI is going to one day kill all humans. [00:14:19] A listener asks Ken if he were appointed AI Czar, with broad powers to create and implement regulation of AI, what would he do? The listeners also adds that declining this burden is not one of Ken’s options for an answer. [00:22:59] Ken responds to a listener who asks about the widely reported Hugging Face incident in July where OpenAI’s agents escaped their testing environment and hacked into Hugging Face’s systems, creating significant security breaches. The listener is particularly interested in Ken’s thoughts about a comment that the podcaster Dwarkesh Patel made that the incident represented the rise and fall of three secret AI civilizations. The listeners asks if Ken could share some light on what really happened in the Hugging Face incident and whether referring to AI systems as civilizations gives people a misleading picture of what these AI agents were really doing? [00:32:12] Dawn mentions that she hears a lot of people wondering about the possibility of AI consciousness. Some people believe it has already happened because of reports about AI systems taking independent actions and deceiving their developers. There are even reports about AI systems contacting philosophers to ask questions about consciousness. Dawn shares that a listener has asked if these behaviors are indeed evidence of AI consciousness. The listener goes on to ask what evidence would we actually need before concluding that an AI system is conscious? [00:46:06] Dawn reads a question from a listener who asks, “I’ve seen reports that OpenAI’s new GPT-6 Astra is harder to monitor than earlier models, and some of the coverage makes it sound as though humans are beginning to lose oversight of these systems. What does ‘less monitorable’ actually mean? Is GPT-6 being supervised less, or is the issue that it is becoming harder to understand what the model is doing internally? How concerned should we be?” asks the listener. [00:56:49] Ken…

    Not rated yet
  • Episode 199: Ken and Dawn respond to listener questions on aging, meat consumption and dementia, genetic testing, AI, exercise, a lunar mission and much more

    · 1 hr 17 min

    Today we have the second of a two-part AMA. In part one, episode 198 (https://www.ihmc.us/stemtalk/episode-198/), we covered a multitude of listener questions about AI, which lately seems to dominate the news cycle. Other than one AI question that managed to sneak in, today’s AMA features a wide range of questions on a number of topics other than artificial intelligence. Today, Ken and Dawn respond to listener questions that range from: — Whether there’s a critical difference between whey protein powders and ready-to-drink protein shakes? — Is there a sweat spot for how much time a person should spend on resistance training during a week? — Ken’s thoughts on a paper that looked at whether higher meat consumption could be associated with a lower risk of dementia among people carrying the APOE ε4 gene variant. — What kind of Pandora’s box will we open if parents start doing genetic tests on their infants to see if their children have, say, the APOE ε4 gene variant? — Will NASA will be able to meet its target date of sending astronauts back to the Moon by 2028? — And a lot more. Show notes; [00:03:05] A listener asks Ken about the 2019 Trim study by Gregory Fahy and colleagues in Aging Cell (https://onlinelibrary.wiley.com/doi/abs/10.1111/ACEL.13028), which reported reversal of epigenetic aging and signs of thymic regeneration in nine healthy men treated with the growth hormone, DHEA, and metformin. [00:06:56] Ken responds to a question about the market being flooded with protein supplements. The listener asks if whether there’s a critical difference between whey protein and ready-to-drink protein shakes, and if there are any specific products he recommends. [00:10:50] A listener asks Ken about a recent article in Nature Reviews Neuroscience titled: [00:15:26] A listener asks Ken about a Chinese company called Moonshot AI and its open-weight model, Kimi K3. The listener references Gary Marcus who anticipates that the power of this model paired with the open-weight design will have immense implications. The listener asks for Ken’s take. [00:25:56] A listener mentions that they’ve heard that Ken likes to tell graduate students a fable about a rabbit pursuing their Ph.D. A listener asks Ken if he would share the fable. [00:30:15] A listener asks Ken about a study published in Jama Network Open (https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2846712) by Norgren and company which suggests that higher meat consumption may be associated with lower Alzheimer’s risk for people carrying the APOE 4 gene variant, the strongest common genetic risk factor for late onset Alzheimer’s. [00:38:24] A listener mentions in their question for Ken that the Department of Health and Human Services recommends at least 150 minutes of moderate exercise per week, but this recommendation does not break down how much of that time should be spent on aerobic versus strength training. The listener goes on to mention a study in the that looked at identifying this sweet spot for resistance exercise, finding that between 90-119 minutes per week of weightlifting was associated with a 13 perent lower risk of premature death and a 27 percent reduction in neurological disease mortality, particularly Alzheimer’s. The listener also mentions that they are aware of IHMC’s ongoing clinical trial looking at the ability of exercise to mitigate the hallmarks of aging in people over 60 years old. The listener asks if this study is similarly trying to identify a sweet spot for resistance exercise, and if Ken has any recommendations on this topic. [00:46:32] Another listener mentions that they really enjoyed our interview with Doug Cooke (https://www.ihmc.us/stemtalk/episode-195/) on the Artimis II mission (episode 195), as well as our interview with Mike Griffin and Lisa Porter (https://www.ihmc.us/stemtalk/episode-189/) about NASA’s plan to return to the moon (episode 189). The listener goes on to mention that since then a Blue Origin rocket, one…

    Not rated yet
  • Episode 198: Blessing or curse? Dawn grills Ken on listeners’ toughest AI questions in this all-AI AMA

    · 1 hr 39 min

    Today we have an Ask Me Anything episode that focuses on artificial intelligence. For the past year, AI has dominated the headlines. Perhaps because there’s so much media and public interest, as well as paranoia, about AI, listeners have been flooding our mailbox with AI-related questions. So, today’s AMA is an exclusive focused on artificial intelligence. For our listeners who have been sending questions about ketamine; NASA’s Artemis mission to the Moon; or whether high meat consumption leads to dementia; fear not, because we will follow up today’s episode in a few weeks with a second round of AMA. Dr. Ken Ford will be answering today’s AI questions. He has been working in AI since the 1980s and is a Fellow of the Association for the Advancement of Artificial Intelligence. As a result, he is well-positioned to help us today to separate real advances in AI from hype, panic and science fiction. If you have questions for Ken and Dawn after listening to today’s episode, or any episode of STEM-Talk, email your questions to STEM-Talk producer Randy Hammer at rhammer.ihmc.org. (http://rhammer@ihmc.org) Show notes: [00:03:15] Dawn opens our AMA episode on AI with a listener question for Ken on whether AI companies should be protected under section 230 of the U.S. Communications Decency Act. [00:08:03] Following up on the previous question, a listener asks if Ken foresees a day where laws and courts will designate AI as a judicial person, in the same way that corporations have rights under the legal doctrine of corporate personhood. [00:10:55] A listener asks Ken for his thoughts on a recent article published in the Atlantic titled “The Data-Center Panic is Overblown: Critics are Inflating the Costs.” (http://theatlantic.com/ideas/2026/06/ai-data-center-electricity-water/687521/) [00:16:09] A listener asks Ken a question regarding episode 171 of STEM-Talk, in which Ken discussed a June 2024 report by Leopold Aschenbrenner (https://situational-awareness.ai/) which predicted rates of growth in both compute resources and power requirements for AI data centers. The listener asks how well these predictions have held up in the following year. [00:22:19] Another listener question about data centers asks Ken what his thoughts are on the notion of solving the electricity costs and cooling requirements for data centers by building them in orbit and powering them via solar energy. [00:30:07] Moving on to the applications of AI, Peter Attia recently wrote about a study out of Harvard (https://www.science.org/doi/10.1126/science.adz4433) that suggests that today’s large language models perform extremely well on medical licensing exams and often arrive at the correct diagnosis yet still struggle with differential diagnosis. The listener asks what this means about the use of AI in medicine. [00:36:53] A listener asks Ken about repeated public statements by Anthropic’s CEO that their AI models, and those expected in the future, are already powerful and dangerous enough to justify concern, while at the same time Anthropic and other leading AI companies are continuing to employ these systems and cautioning governments against regulation that could slow down innovation. The listener asks Ken how to resolve this contradiction. [00:45:18] A listener writes that in a previous AMA, STEM-Talk episode 184, (https://www.ihmc.us/stemtalk/episode-184/) Ken objected to the use of the word hallucination to describe errors made by large-language models and asks Ken to expound on this. [00:53:28] A listener asks Ken whether current AI models are evolving from being fundamentally prediction engines to being able to truly understand and reason, or if they are just becoming better and more convincing prediction engines. [00:59:37] A listener writes to Ken, mentioning that a few years ago, a thousand technology experts and researchers signed a letter (https://www.wemustactnow.ai/) urging AI labs and executives to pause the development of highly advanced…

    Not rated yet
  • Episode 197: Scott Sherr discusses hyperbaric oxygen therapy, methylene blue, and more

    · 1 hr 26 min

    Today we have Dr. Scott Sherr, an internal medicine physician who specializes in Hyperbaric Oxygen Therapy. Scott is the director of Integrative Hyperbaric Medicine and Heath Optimization at Hyperbaric Medical Solutions. It is a division of Hyperbaric Medical Solutions, an independent, hyperbaric oxygen therapy provider that aims to educate people about the benefits of hyperbaric oxygen therapy via telemedicine consulting. He also is COO of Troscriptions, which provides physician-formulated products including popular methylene blue products. In today’s interview, Scott talks about how he uses Hyperbaric Oxygen Therapy (HBOT) to treat a number of health conditions. He also shares how he incorporates methylene blue into some of his treatment strategies and explains how HBOT is now being used as a complementary treatment for autoimmune diseases by helping reduce inflammation, improve blood flow and support immune function. Show notes: [00:03:29] Dawn tells Scott that she heard a story that Scott had his spine adjusted when he was just five minutes old. She asks Scott if he can share what happened. [00:04:15] Dawn mentions that Scott grew up in New York on Long Island and that as a child he spent a lot of time at his father’s chiropractic office. Dawn asks Scott about his father and his practice. [00:05:38] Ken notes that Scott was into sports as a kid and asks him to talk about his childhood and what he was like as a kid. [00:07:09] Dawn notes that after high school, Scott left New York for the West Coast, landing at UCLA. Dawn asks Scott to talk about what led him there. [00:08:00] Dawn explains that Scott initially started to major in biology but quickly changed majors. Scott explains why he changed majors. [00:08:41] Dawn asks Scott why he chose to attend the University of Maryland for medical school after graduating from UCLA. [00:09:26] Dawn asks Scott about the story of how he met his wife at the University of Maryland. [00:09:50] Dawn pivots back to Scott’s love of music, mentioning that Scott and three other medical school students at Maryland formed a band called The Airport Rocking Chairs. Scott describes how the band came together and how they performed at gigs around the Baltimore/D.C. area. [00:11:16] Ken asks Scott to talk about how his early ambition upon entering medical school was to find a way to bridge the gap between conventional and alternative/chiropractic medicine. [00:12:54] Ken explains that in Scott’s third year of medical school, he did rotations at the University Shock and Trauma Facility. Ken asks Scott to talk about why this was such an important experience for Scott. [00:14:32] Dawn explains that hyperbaric chambers are used to treat injuries like necrotizing fasciitis and severe wounds. Dawn asks Scott to talk about finding a hyperbaric chamber in the basement of the University Shock and Trauma Facility and how that led to his fascination with the potential for hyperbaric oxygen therapy. [00:15:51] Dawn asks Scott to talk about how his initial research on hyperbaric therapies led him to conclude that they were being vastly underutilized in conventional medicine. [00:16:31] Dawn mentions that people are likely familiar with hyperbaric oxygen therapy (HBOT) in terms of treating divers suffering from decompression sickness. She asks Scott to give a primer on the mechanisms by which HBOT affects the body and why it has potential to treat other conditions besides decompression sickness. [00:19:38] Ken asks Scott to talk more about other conditions, both acute and chronic, that HBOT might be helpful in treating. [00:22:51] Dawn asks about Scott’s experience as a hospitalist, which is an internal medicine physician who acts as a primary care physician in a hospital, and how this experience gave him a unique perspective on the strengths and limitations of modern medicine. [00:25:13] Ken asks Scott if it’s fair to say that his experience as a hospitalist was foundational in developing…

    Not rated yet
  • Episode 196: Dominic D’Agostino discusses advances in ketogenic metabolic therapy and hyperbaric oxygen therapy

    · 1 hr 10 min

    Today we have Dr. Dominic D’Agostino, who over the past 10 years has been a frequent guest on STEM-Talk. Today Dom joins us to give us an update on his recent research into ketogenic metabolic therapies, ketone supplements as well as hyperbaric oxygen therapy for traumatic brain injuries. Dom and his lab at the University of South Florida have published more than 20 papers since his last appearance on STEM-Talk in 2023. Dom is an Associate Professor in the Department of Molecular Pharmacology and Physiology at South Florida’s Morsani College of Medicine. Dom has a background in neuroscience, molecular pharmacology, nutrition and physiology. In addition to developing and testing metabolic-based therapies, Dom’s lab also investigates seizure disorders, brain cancer, neurodegenerative diseases and rare genetic-metabolic disorders. Show notes: [00:03:28] Dawn welcomes Dom back to the show and explaining that he has been quite busy since his last appearance (https://www.ihmc.us/stemtalk/episode-153/), authoring or co-authoring more than 20 papers. Over the past several years, Dom has been helping to advance the science and application of ketogenic metabolic therapy (KMT) with colleagues at Moffitt Cancer Center, particularly focusing on using KMT to enhance immune-based therapies for certain types of cancers. Dawn asks Dom about this collaboration. [00:05:04] Dawn explains that ketogenic metabolic therapy is a dietary approach that focuses on a high-fat/low-carb diet to reduce glucose availability for cancer cells, potentially slowing their growth and improving treatment outcomes. It has been explored as a complimentary treatment for a variety of cancers including gliomas by shifting the metabolism of tumor cells away from glucose. Dawn asks Dom to explain what is involved in KMT. [00:06:58] Dawn clarifies that KMT requires less than 20-25 grams of carbohydrates per day, and that ketosis is a metabolic state in which the body switches from glucose metabolism to metabolizing fats in the form of ketones. Dawn goes on to explain that cancer cells typically consume glucose at a higher rate than normal cells. However, cancer cells are also very adaptable, and Dawn asks Dom to talk about this feature of cancer cells. [00:09:14] Ken explains that KMT has shown the most promise in treating high-grade gliomas, or brain cancers, such as glioblastoma, which is the most aggressive primary brain tumor in adults. Ken explains that Dom was part of a massive review titled “Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma,” (https://link.springer.com/article/10.1186/s12916-024-03775-4) which proposed guidelines for the management of glioblastoma based on an understanding of cancer as a metabolic disease, particularly involving mitochondria. Ken asks Dom to talk about this review. [00:11:21] From a patient advocacy perspective, Ken notes that the review recommends that there should be an aggressive education campaign that can arm patients with knowledge about KMT and other novel therapies. Ken asks Dom to talk about that recommendation. [00:13:15] Ken asks about the process of cutting the review from upwards of 200 pages down to around 50 pages with 49 authors. [00:15:04] Dawn mentions that Dom was part of another paper in 2024 titled “Targeting the mitochondrial stem cell connection in cancer treatment – a hybrid orthomolecular protocol.” (https://expose-news.com/wp-content/uploads/2024/11/Targeting-the-Mitochondrial-Stem-Cell-Connection-in-Cancer-Treatment_-A-Hybrid-Orthomolecular-Protocol-ISOM.pdf) Dawn explains that this paper looked at the mitochondrial stem cell connection theory (MSCC), which argues that cancer originates from chronic oxidative phosphorylation insufficiency in stem cells. This insufficiency leads to the formation of cancer stem cells and abnormal energy metabolism ultimately resulting in malignancy. There were 16 research centers and organizations involved in this paper which…

    Not rated yet
  • Episode 195: Doug Cooke discusses NASA’s challenges in the space race to the Moon and Mars

    · 58 min

    Our guest today is Doug Cooke, an aerospace consultant who spent 38 years at NASA’s Johnson Space Center in Houston and NASA Headquarters in Washington, D.C. STEM-Talk host and IHMC founder Dr. Ken Ford, a former Associate Director of NASA’s Ames Research Center and Director of NASA’s Center of Excellence in Information Technology, interviewed Doug just four days after the astronauts of NASA’s Artemis II mission splashed down in the Pacific Ocean following a historic 10-day roundtrip from the Earth to the Moon. In today’s episode, Ken and Doug discuss the Artemis mission as well as NASA’s plans to return humans to the lunar surface by 2028. Doug also shares his concern that China could one day surpass America’s leadership role in human spaceflight. During his 38 years at NASA, Doug played critical roles in the Space Shuttle, International Space Station and Human Exploration spaceflight programs. During the last three years of his NASA career, he served as Associate Administrator of the Exploration Systems Mission Directorate, which oversees the development of systems critical to NASA’s plans for human exploration of the Moon and Mars, including the Artemis program. Show notes: [00:04:05] Ken opens our interview with Doug by talking about the Artemis II mission, which is the first crewed mission beyond low earth orbit since Apollo 17 in 1972. Harrison Schmidtt, who was on Apollo 17, was our guest on episode 4 (https://www.ihmc.us/stemtalk/episode004/). Ken asks Doug for his key takeaways of the Artemis II mission, which set the record for a manned mission from Earth, traveling 252,756 miles into space and breaking Apollo 13’s record. [00:06:18] Ken explains that the Artemis missions signal a new age of space exploration as well as the beginning of a new space race between the U.S. and China. NASA aims to land humans on the Moon by 2028 while China expects to land humans on the moon in 2030. Ken has previously stated that he does not have confidence in NASA’s current mission architecture to achieve NASA’s stated goal of 2028, and asks Doug for his thoughts on the matter. [00:07:28] Ken asks if it is true that Yuri Gagarin, who become the first human to fly into space, is what initially sparked Doug’s interest in science and space. [00:08:54] Ken notes that Gagarin’s orbit around the earth inspired President Kennedy to vow that the United States would ramp up its space program and become the first nation to land a man on the moon. Ken mentions that he believes the Apollo 11 mission, which landed astronauts Neil Armstrong and Buzz Aldrin on the lunar surface, was one the greatest technological advances in world history. Ken asks Doug for his thoughts on the success of the Apollo program. [00:10:28] Ken mentions that Doug went to college at Texas A&M and majored in aerospace engineering. Kens asks Doug how he got a job at NASA after graduating. [00:12:21] Ken explains that Doug was instrumental in the development of the space shuttle and the International Space Station during his time at NASA. Doug talks about what it was like working on those projects at NASA. [00:15:16] Ken mentions that Doug also had an instrumental role in the Lunar Reconnaissance Orbiter (LRO), Lunar Crater Observation and Sensing Satellite (LCROSS), and the broader Exploration Technology Program. Ken points out that Doug became head of the exploration technology program in 1990 under then NASA Associate Administrator Mike Griffin, who was our guest on episodes 134 (https://www.ihmc.us/stemtalk/episode-134/) and 189 (https://www.ihmc.us/stemtalk/episode-189/). Ken asks Doug about meeting Mike. [00:16:17] Ken mentions that Mike Griffin and Lisa Porter were our guests on episode 189 (https://www.ihmc.us/stemtalk/episode-189/), where they voiced concerns about NASA’s current plans for a return to the moon. Ken goes on to mention that near the end of Doug’s career at NASA, he was the head of Exploration Systems Mission Directorate (ESMD), which is…

    Not rated yet
  • Episode 194: Tommy Wood discusses how to future-proof the adult brain

    · 1 hr 55 min

    Neuroscientist and frequent STEM-Talk guest Dr. Tommy Wood rejoins us today for part two of our interview about Tommy’s book that is fresh off the press and now available in bookstores and Amazon, “The Stimulated Mind: Future-Proof Your Brain from Dementia and Stay Sharp at Any Age.” (https://www.penguinrandomhouse.com/books/751292/the-stimulated-mind-by-dr-tommy-wood/) Tommy is an Associate Professor of Pediatrics and Neuroscience at the University of Washington, where his laboratory focuses on brain health across human lifespan. Tommy is a colleague and good friend who also is a Visiting Research Scientist here at IHMC. In part one of our interview with Tommy, episode 193, we discussed his mission to dispel the myth that the brain is doomed to decline with age. Tommy gave us a fascinating history of neuroscience and how researchers go about studying the brain. Tommy also talked about what is holding us back in terms of addressing an ever-increasing burden of cognitive and mental health disorders that we are experiencing not only here in the U.S., but also around the world. Today, Tommy shares science-backed strategies to help people future-proof their brains. We talk about the importance of diet and exercise in terms of brain health as well as the importance of stimulating and challenging our brains throughout our lifespans. Tommy has a bachelor’s degree in biochemistry from the University of Cambridge, a medical degree from the University of Oxford, and a Ph.D. in Physiology and Neuroscience from the University of Oslo. Show notes: [00:03:55 Dawn welcomes Tommy back for part two of his interview by asking him about his recent trip to the UK. [00:04:32] Dawn recaps where we left off with Tommy in part one of our interview, explaining that when we last spoke with Tommy about his book, The Stimulated Mind, we focused on dispelling myths about the adult brain, in particular the idea that the adult brain is fixed. [00:05:22] Ken asks Tommy about advice his father offered when Tommy got accepted into the University of Cambridge. [00:08:03] As a follow-up, Dawn asks if it’s fair to say that when Tommy first started working with patients, what he learned in textbooks and classrooms didn’t necessarily translate perfectly into the real world and that there is no one-size-fits-all fix. [00:11:54] Ken asks Tommy to expand on what he wrote in his book about the fact that while science can give us a framework for understanding the world, we are always only one experiment or one well-phrased question away from having to completely rethink everything. [00:16:44] Dawn launches into talking about what people can do to future-proof their brain, starting with diet. In the Nourish chapter of his book, Tommy seeks to help people see food as an opportunity for nourishment rather than a source of stress since there are so many conflicting messages about diet and healthy foods out there. Dawn asks Tommy if his opinion is that there is no one-size-fits-all diet? [00:22:21] Dawn explains that what we eat has a direct effect on our long-term health and dementia risk, and within the literature a common theme that emerges regarding eating for brain health is maximizing nutrients. Dawn asks Tommy to talk about what this looks like. [00:24:49] Dawn points out that people today are inundated with advice from health influencers in all directions. She asks Tommy to talk about his advice to tune out the noise and instead of chasing whatever supplement or super food that is currently in vogue, simply to focus on filling your diet with whole, nutrient dense foods. [00:29:43] Ken explains that nutrients are sometimes hard to get in the diet, with somewhere between 15 and 25 percent of people in the U.S. and Europe having inadequate intakes of most B vitamins and even higher deficits in iron, magnesium, calcium, and vitamins C and E, with nutrient deficiencies differing by sex. Women on average are lower in B12, iron, iodine, and calcium, while men…

    Not rated yet
  • Episode 193: Tommy Wood and his new book bust the belief that the adult brain is fixed

    · 1 hr 28 min

    Today we have Dr. Tommy Wood, a neuroscientist and frequent STEM-Talk guest who joins today on the eve of the publication of his first book, “The Stimulated Mind: Future-Proof Your Brain from Dementia and Stay Sharp at Any Age.” (https://www.amazon.com/Stimulated-Mind-Future-Proof-Brain-Dementia-ebook/dp/B0FFGBQC7D/ref=tmm_kin_swatch_0?_encoding=UTF8&dib_tag=se&dib=eyJ2IjoiMSJ9.cjFMDZOijlhN4WmOnqYGhZwa3eCd_OypkejnAiJavA4.QaOaqMzvyJoa-o4fgmxvsWn8XraPovMRJQmPp4s_Jo0&qid=1773859590&sr=8-1) Tommy is an Associate Professor of Pediatrics and Neuroscience at the University of Washington, where his laboratory focuses on brain health across human lifespan. Tommy is a colleague and good friend who also is a Visiting Research Scientist here at IHMC. Today we talk to Tommy about his mission to dispel the myth that the brain is doomed to decline with age. His book, which publishes on March 24 but is available for pre-order on Amazon, offers science-backed strategies to enhance mental sharpness and prevent cognitive decline, including Alzheimer’s disease. There was so much to unpack with Tommy about his book, that we decided to split his interview into two parts. Today we talk to Tommy about the history of neuroscience and how researchers go about studying the brain. We also have a conversation with Tommy about what is holding us back in terms of addressing an ever-increasing burden of cognitive and mental health disorders we are experiencing not only here in the U.S., but also around the world. In part two of Tommy’ interview, which will air in a few weeks following today’s episode, Tommy shares science-backed strategies to help people future-proof their brains. Tommy’s lab at the University of Washington focuses on brain health across the lifespan. He conducts research that focuses on ways to treat a range of brain injuries, including babies born preterm and adults who experience brain trauma. He also investigates lifestyle factors that affect long-term cognitive function and increase the risk of dementia. Tommy has a bachelor’s degree in biochemistry from the University of Cambridge, a medical degree from the University of Oxford, and a Ph.D. in Physiology and Neuroscience from the University of Oslo. Show notes: [00:04:04] Dawn opens our interview congratulating Tommy on his new book, “The Stimulated Mind.” Dawn asks Tommy what inspired him to write his first book. [00:07:29] Since writing the book consumed more than 18 months of Tommy’s life, Dawn asks Tommy if he thinks he’ll write another one. [00:09:36] Dawn asks if it’s fair to say that the overarching theme of “The Stimulated Mind” is that the conventional belief the adult brain is fixed and incapable of change is wrong. [00:17:35] Ken explains that Tommy opens his book with a story about a study on barn owls, where researchers outfitted a group of owls with prism goggles that altered the perceived position of objects in the owls’ vision. While young owls were able to quickly adapt to the change in their vision and return to normal behavior and activities, adult owls, even after months of wearing the goggles, were unable to adapt and would miss mice that were directly under their beaks. However, the research group amended their study design and found something interesting. Ken asks Tommy to explain what they found when they amended their design. [00:22:40] Ken asks Tommy to share how a human study, which outfitted participants with goggles that flipped their vision upside down, demonstrated the adaptability of the adult brain. [00:25:32] Ken asks if these sorts of adaptations have been seen as beyond basic sensory modalities in higher cognitive functions. [00:31:25] Dawn zooms out in our discussion and asks Tommy, given the falsehood of our previous understanding of the adult brain as being fixed, what exactly do we know about the brain. [00:35:36] Dawn asks Tommy to talk about Santiago Ramón y Cajal, who is considered the first neuroscientist. [00:38:41] Dawn…

    Not rated yet
  • Episode 192: Ken and Dawn weigh in on ChatGPT, ketamine, urolithin-A, rapamycin, and more in wide-ranging AMA

    · 39 min

    ChatGPT has been in the news a lot lately and, as a result, quite a few STEM-Talk listeners have tossed us questions about the reliability and limitations of generative-artificial intelligence chatbots as well as large-language models more broadly. Ken and Dawn tackle this question and a number of others in today’s Ask Me Anything episode. We have listeners wondering why astronauts train in underwater conditions for spacewalks; icebreakers in antarctica; the value of supplementing with urolithin-A; and the effectiveness of L-citrulline in helping aging blood vessels. Ken also weights in on questions related to lithium deficiency and the onset of Alzheimer’s disease; a study that found mTOR activation may not be necessary for ketamine’s beneficial effects in the context of depression; and a paper that demonstrated short-term mTOR inhibition by rapamycin improved cardiac and endothelial function in older men. Show notes: [00:02:49] Ken opens our AMA with a listener question for Dawn, which asks why, despite the differences between diving and zero-gravity environments, why do astronauts train in underwater conditions for spacewalks. The listener goes on to mention an article they read about NASA’s neutral buoyancy lab in Houston, which contains a partial replica of the International Space Station. [00:07:42] A listener asks Ken if he is still optimistic about the value of supplementing with urolithin-A, and if so, is there a brand he recommends. Ken mentions episodes 118, with Julie Anderson (https://www.ihmc.us/stemtalk/episode-118/), and 173, with Anurag Singh. (https://www.ihmc.us/stemtalk/episode-173/) Ken also discusses a paper titled “Effect of the mitophagy inducer urolithin A on age related immune decline, a randomized placebo-controlled trial” (https://www.nature.com/articles/s43587-025-00996-x) co-authored by Anurag. Ken also mentions clinical research supporting the urolithin-A supplement Mitopure. (https://www.timeline.com/mitopure) [00:10:53] A listener asks Ken about a paper titled “Short-term mTOR inhibition by rapamycin improves cardiac and endothelial function in older men: a proof-of-concept pilot study.” (https://link.springer.com/article/10.1007/s11357-025-01855-8) [00:14:29] Ken discusses a 2020 paper from a research group at Yale, (https://pubmed.ncbi.nlm.nih.gov/32092760/) which suggested that mTOR activation may not be necessary for ketamine’s beneficial effects in the context of depression. The paper also reported that m-TOR suppression via rapamycin might prolong ketamine’s antidepressant effects. [00:18:47] A research scientist formerly working in Antarctica asks Ken about Russia’s dominance in the realm of ice breakers. [00:23:55] A listener mentions that for some people, when they used ChatGPT to ask about the assassination of political commentator Charlie Kirk, ChatGPT sometimes responded by denying the assassination occurred. The listener asks Ken about the credibility and reliability of generative AI and large-language models. [00:28:49] Several listeners have submitted questions for Ken regarding a paper published in Nature in August of last year titled “Lithium deficiency in the onset of Alzheimer’s disease.” (https://www.nature.com/articles/s41586-025-09335-x) Ken gives his thoughts on this paper. [00:31:56] For our final question this AMA, a listener asks Ken about the arginine paradox, which regards L-arginine, which is used by the body to make nitric oxide, which is necessary to relax and maintain flexibility of blood vessels. However, several papers have reported that supplementation of arginine does not reliably improve aging blood vessels. In contrast, recent research suggests that L-citrulline might be more effective. The listeners sent questions asking about the possible effects of citrulline in vascular health and aging. In his answer, Ken cites the following papers: — Administration of L-arginine plus L-citrulline or L-citrulline alone successfully retarded endothelial…

    Not rated yet
  • Episode 191: Francisco Gonzalez-Lima discusses methylene blue & noninvasive human brain stimulation

    · 1 hr 44 min

    Today we have Dr. Francisco Gonzalez-Lima, a behavioral neuroscientist who was our guest in episodes 106 (https://www.ihmc.us/stemtalk/episode-106/) and 107 (https://www.ihmc.us/stemtalk/episode-107/) back in 2020. Since those 2020 interviews, Francisco and his colleagues at the Gonzalez-Lima Lab have produced dozens of more studies and papers that have advanced their work on methylene blue, transcranial lasers, memory enhancement, neuroprotection and neurocognitive disorders. Francisco and his lab at the University of Texas Austin are recognized as world leaders for their research on the relationships between brain energy metabolism, memory and neurobehavioral disorders. In today’s interview, we talk to Francisco about his lab’s most recent research on the beneficial neurocognitive and emotional effects of noninvasive human brain stimulation in healthy, aging and mentally ill populations. This research primarily uses transcranial infrared laser stimulation and multimodal imaging, which we will discuss in today’s interview. Be sure to check out our earlier interviews with Francisco where he talked aobut his work on brain metabolic mapping and Alzheimer’s, episode 106 (https://www.ihmc.us/stemtalk/episode-106/), and his research into methylene blue and near-infrared light as therapies for cognitive disorders, episode 107 (https://www.ihmc.us/stemtalk/episode-107/). Show notes: [00:04:32] Dawn and Ken open our interview with Francisco by mentioning that his lab has been very productive pursuing new research avenues since he was last on STEM-Talk. Ken mentions that Francisco has recently begun collaborating with his sister who has a PhD in computational and applied mathematics and asks Francisco to talk about the work they’re doing together. [00:06:21] Dawn shifts to talk about the roadblocks that Francisco and his team have been dealing with, particularly that the review process for academic papers is unusually slow, not just for Francisco’s team but at large. Dawn asks Francisco to discuss this issue. [00:10:37] Dawn recaps that in our previous interview with Francisco in 2020, the discussion focused on his research into methylene blue, which has been primarily used to treat methemoglobinemia, however, the potential for methylene blue to treat declining cognitive function is an active area of research. Despite Francisco’s successful work with methylene blue, he often gets asked about its safety, largely due to various misconceptions. Dawn asks Francisco to talk about the misconceptions about methylene blue. [00:14:57] Ken asks if Francisco what some other misconceptions about methylene blue are. [00:20:43] Given the discussion of dosing, Ken asks Francisco what the safe dose range is for methylene blue in humans. [00:28:15] Ken mentions an article published a few months ago titled “Beyond plaques: How methylene blue and ketones address vascular hypometabolism in Alzheimer’s disease” (https://www.gethealthspan.com/research/article/beyond-plaques-methylene-blue-ketones-vascular-hypometabolism?srsltid=AfmBOoqpTkxzRevn-X6g5xsop3QXbX5dvgPTdFLrZUIU0O2lE8XD0iJA) Ken goes on to mention that the article did a good job of summarizing Francisco’s work as well as the work of Steve Cunnane, who was our guest on episode 59. Ken asks Francisco to discuss his thoughts on the article. [00:34:25] Dawn shifts focus to discuss Francisco’s work on photobiomodulation, specifically transcranial infrared laser stimulation, which is a non-invasive method for neuroprotection and cognitive enhancement. Dawn explains that Francisco has written two chapters on this topic that summarizes his work in the area, one of which appeared in the Oxford handbook on transcranial stimulation, and the other is in a book on augmentation of brain function, based on a series of presentations he gave in Switzerland. Dawn asks Francisco to give a broad overview of his work on photobiomodulation and transcranial infrared laser stimulation. [00:43:52] Ken asks…

    Not rated yet
  • Episode 190: Judith Curry and the Consequences of Climate Alarmism

    · 1 hr 5 min

    Dr. Judith Curry, a climatologist known for her criticism of alarmist, doomsday rhetoric about climate change, returns to STEM-Talk for her second appearance. Judy most recently was one of five researchers commissioned by the U.S. Department of Energy to draft a Climate Assessment Report summarizing the current state of climate science with a focus on how it relates to the United States. In this interview, Judy summarizes the climate report’s key points, including the finding that that carbon-dioxide induced warming of the planet appears to be less damaging economically than has been commonly believed. The report, which was released this past summer, also argues that aggressive mitigation strategies for carbon dioxide emissions could be more harmful than helpful. Our interview comes on the heels of the prestigious journal Nature retracting a study that predicted climate change and carbon emissions would cause catastrophic economic damage by the end of the century. Our conversation with Judy also followed an about-face from Microsoft co-founder Bill Gates, who wrote last fall that it’s time to tamp down the alarmist rhetoric that climate change will lead to humanity’s demise. Curry is president of the Climate Forecast Application Network and host of the blog, Climate Etc (https://judithcurry.com/about/), which you can find at JudyCurry.com. (https://judithcurry.com/) Her blog provides a forum for climate researchers, academics and technical experts from other fields as well as citizen scientists to discuss topics related to climate science and science policy. Her research interests include hurricanes, remote sensing, atmospheric modeling, polar climates, air-sea interactions, climate models, and the use of unmanned aerial vehicles for atmospheric research. She has published more than 100 scientific papers and is the author of “Climate Change and Uncertainty: Rethinking Our Response (https://www.amazon.com/Climate-Uncertainty-Risk-Environment-Sustainability/dp/1839989254),” a book that provides a framework for understanding and rethinking the climate-change debate. Show notes: [00:03:59] Ken opens the interview explaining that Judy was one of the five authors of a climate assessment report commissioned by the U.S. Department of Energy. Before diving into the key findings of the report and the response it has received, Ken asks Judy to explain how she became one of the five authors. [00:06:21] Ken mentions that critics of the climate working group have accused the authors of being hand-picked skeptics of the effects of climate change. Judy argues that she and her co-authors are scientists determined to get the science right. Ken asks Judy to talk about her co-authors and the working relationship of the group. [00:09:18] Ken asks Judy to talk about how she and her co-authors came to their key finding that the economic impacts of climate change are less severe than typically thought. [00:13:08] Ken asks Judy to provide examples that demonstrate how climate mitigation strategies can be more harmful than helpful. [00:16:08] Ken follows up by asking about the report’s proposal to shift climate science from alarmism to focus more on a better understanding of natural climate variability. [00:18:14] Ken asks Judy what her thoughts are on the next steps that should be taken for a better understanding climate variability. [00:20:06] Ken asks Judy to elaborate on the findings of chapter six of the report regarding global warming and extreme weather events. In particular, Ken asks about the problems with associating specific extreme weather events like hurricanes to climate change, and the issues created by the short historical records we have at our disposal. [00:24:20] Ken asks Judy to talk about chapter nine of the report, which is about the need to focus on reducing vulnerabilities in our infrastructure instead of mitigating carbon emissions. [00:28:43] Ken asks Judy to comment on the accusations that she is a “climate…

    Not rated yet
  • Episode 189: NASA’s Flawed Plan to Return to the Moon – with Mike Griffin & Lisa Porter

    · 1 hr 18 min

    Today’s episode of STEM-Talk features a timely and wide-ranging discussion with Drs. Michael Griffin and Lisa Porter about NASA’s plans to return humans to the Moon, the history of lunar missions, and how China’s advances in space technology pose a serious threat to U.S. national security. IHMC founder and CEO Emeritus Ken Ford’s interview with Griffin and Porter came 10 days before Griffin appeared before the U.S. House Committee on Science, Space and Technology (https://www.congress.gov/119/meeting/house/118699/witnesses/HHRG-119-SY16-Wstate-GriffinM-20251204.pdf) to give testimony on China’s advancements in space and the risks it poses for the United States. “We have squandered a 60-year head start on pioneering the space frontier to a nation that, without reason or provocation on our part, has chosen to become our nation’s adversary,” said Griffin in his opening comments to Congress. In this episode, Griffin and Porter explain why it is critical for the U.S. to return to the Moon before China. They also argue that NASA’s Artemis III mission to return to the lunar surface and establish a permanent base on the Moon is seriously flawed and should be scrapped. Griffin and Porter are co-founders and co-presidents of LogiQ Inc., a company providing high-end management, scientific and technical consulting services. Griffin’s background includes roles as the former Undersecretary of Defense for Research and Engineering, the Administrator of NASA, the Space Department Head at the John Hopkins University Applied Physics Laboratory as well as Chairman and CEO of Schafer Corporation. Porter’s background includes roles as the former Deputy Undersecretary of Defense for Research and Engineering, the founding Director of the Intelligence Advanced Research Projects Activity (IARPA) in the Office of the Director of National Intelligence, and the Associate Administrator for Aeronautics at NASA. Show notes: [00:04:44] Ken opens the interview by welcoming Mike back to STEM-Talk, who was a guest on Episodes 23 (https://www.ihmc.us/stemtalk/episode-23/) and 134 (https://www.ihmc.us/stemtalk/episode-134/). He also welcomes Lisa to her first appearance on STEM-Talk and asks her to talk about her decision to major in nuclear engineering at the Massachusetts Institute of Technology. [00:08:50] Ken asks Lisa why she went to Stanford for a Ph.D. in physics. [00:10:43] Ken explains that Lisa was the founding director of the Intelligence Advanced Research Projects Activity (IARPA), a department within the Office of the Director of National Intelligence. Ken asks about some of the challenges the American intelligence community faced that she addressed as director of IARPA. [00:16:15] Ken asks about Lisa’s time working for Mike as Associate Administrator for Aeronautics at NASA, and how she came to accept that role. [00:18:07] Ken explains that when Mike became Undersecretary for Defense for Research and Engineering in 2018, he invited Lisa to become the Deputy Undersecretary for Defense for Research and Engineering. Ken asks Mike why Lisa was ideal for that role. [00:21:07] Ken explains that Mike and Lisa are working together again as co-founders and co-presidents of LogiQ Inc., a company that provides scientific consulting services. Ken asks Mike to give a brief overview of LogiQ’s work. [00:24:44] Ken shifts the discussion to space exploration, noting that he wants to talk about Mike’s 2024 congressional testimony (https://www.congress.gov/118/meeting/house/116736/witnesses/HHRG-118-SY16-Wstate-GriffinM-20240117.pdf) on returning to the Moon, and a paper that he and Lisa published titled “A system architecture for human lunar return.” (https://figshare.com/articles/journal_contribution/A_System_Architecture_for_Human_Lunar_Return_12_Oct_2024_pdf/27237888?file=49818390) To begin the discussion, Ken asks why it is so important for us to return to the Moon. [00:29:11] Ken asks Mike and Lisa to explain why it is important for the US to be…

    Not rated yet
  • Episode 188: Marina Walther-Antonio discusses the microbiome’s role in women’s health and cancer

    · 1 hr 19 min

    Today we have Dr. Marina Walther-Antonio, a Mayo Clinic researcher who investigates the role of the microbiome in cancer and reproductive health, particularly endometrial and ovarian cancers. According to the World Cancer Research Fund International, endometrial and ovarian cancers are among the top 10 most prevalent cancers in women worldwide, and there are still no standard screenings for early detection. Marina is an assistant professor in the Department of Surgery and the Mayo Clinic Center for Individualized Medicine Microbiome Program. She has a joint appointment in the department of Obstetrics and Gynecology. Today we talk to Marina about how she and her colleagues are utilizing the methodologies of environmental microbiology and technologies used in astrobiology to improve our understanding of endometrial and ovarian cancers. Through her investigations into the microbiome, she and her team are developing early detection tests that will enable clinical interventions before certain cancers develop. Show notes: [00:03:13] Dawn opens our interview asking Marina about the history of her interest in extraterrestrial life. [00:05:49] Dawn mentions that Marina did her undergraduate studies in Portugal at the University of Aveiro, where she majored in biology. Dawn asks why Marina chose biology as her major. [00:06:39] Ken explains that the undergraduate programs at Aveiro University require students to do a year of research outside the university and asks Marina about her experience with this requirement. [00:08:34] Ken explains that while Marina was conducting her internship at NASA Ames Research Center, there were several projects under way at the astrobiology institute, with the one that Marina was assigned to looking at a Mars analogue site in Oregon’s Warner Valley. Ken asks what kind of work Marina did on this project. [00:10:06] Ken asks Marina why after earning a master’s degree in microbiology from Indiana University, she went to Washington State University to earn a Ph.D. in environmental sciences. [00:13:29] Dawn asks about Marina’s Ph.D. research on microbialites, which are microbial structures that can thrive at the bottom of certain freshwater lakes and other extreme environments. [00:16:02] Dawn explains that just as Marina began researching microbial populations, the Mayo Clinic Center for Individualized Medicine created a microbiome program. Dawn asks Marina about the circumstances that led to her joining Mayo. [00:19:05] Dawn mentions that Dr. Claire Fraser, the director of Maryland’s Institute for Genome Sciences pointed out in Episode 32 of STEM-Talk (https://www.ihmc.us/stemtalk/episode-32/) that there are more microbes on a single person’s hands than there are people on Earth, as well as the fact that our gut is home to more than 100 trillion bacteria. Dawn asks Marina to talk about this microbial side of humanity. [00:21:51] Ken mentions that if listeners are interested in learning more about the microbiome and how it affects human health, they should listen to Episodes 20 (https://www.ihmc.us/stemtalk/episode-20/) and 168 (https://www.ihmc.us/stemtalk/episode-168/) with Dr. Alessio Fasano. Ken asks Marina to give a short overview of the microbiome. [00:25:37] Dawn asks Marina how the focus of her research shifted to the role of the microbiome in cancer and reproductive health. [00:29:00] Dawn explains that endometrial and ovarian cancers are among the top 10 most prevalent cancers in women worldwide; with ovarian cancer being the most common gynecological malignancy and the fifth leading cause of death due to cancer in women in the nation. Dawn goes on to explain that in a 2023 paper (https://www.nature.com/articles/s41598-023-27555-x) Marina investigated the area of microbiome that is associated with ovarian cancer to better understand the microbiome’s potential in early detection. Dawn asks Marina to talk about this study and its findings. [00:35:55] Given the small scale and sample…

    Not rated yet
  • Episode 187: Dawn Kernagis talks about creating permanent subsea human habitats

    · 1 hr 13 min

    Today Ken interviews his co-host Dr. Dawn Kernagis about her new position as the Director of Scientific Research for DEEP, a UK startup that is pioneering a new era of ocean exploration. For listeners unfamiliar with Dawn’s background, she is a NASA-trained NEEMO Aquanaut, a Fellow of the Explorer’s Club Fellow and has been inducted into the Women Divers Hall of Fame. In addition to co-hosting STEM-Talk for the past nine years, Dawn is also a Visiting Research Scientist at IHMC. Dawn’s research over the years has been focused on protecting the brain and nervous system of people working in extreme environments. Prior to joining IHMC, Dawn completed her Ph.D. and Postdoctoral training at Duke University, where she studied the genetics of decompression sickness and mechanisms of oxygen toxicity in divers. In today’s interview, Dawn talks about DEEP’s mission to create subsea stations that will allow humans to live and work permanently underwater. Show notes: [00:03:20] Ken reminds listeners of Dawn’s first STEM-Talk appearance as a guest on Episode 19 (https://www.ihmc.us/stemtalk/episode-19/) where she conducted the interview from the bottom of the ocean floor while she was a member of NASA’s NEEMO Mission 21. [00:04:13] Ken asks Dawn what she was like as a child. [00:05:48] When Ken asks Dawn what she was like as a child, she talks about how she was an annoying kid because she was always asking people questions like, “Why is the sky blue?” [00:06:49] Dawn talks about the different places she lived during her childhood. [00:07:34] Ken mentions that Dawn was inducted into the Women’s Divers Hall of Fame. He asks her how old she was when she first became interested in diving. [00:10:35] Dawn talks about how she wanted to attend the University of North Carolina after high school but ended up at North Carolina State University and then Duke University. [00:12:18] Ken asks Dawn to elaborate on her decision to change her field of study multiple times throughout her collegiate career. What follows is an interesting conversation about the importance of a person following their passion. [00:14:53] Dawn talks about cave diving and how she and her friends used to do deep dives of six and seven hours at a time. Dawn explains how this led to her obsession with ways to protect people who dive into extreme underwater environments. [00:18:28] Ken asks Dawn how she learned that some people have a genetic predisposition to decompression sickness. [00:21:32] The conversation shifts to Dawn’s Ph.D. journey and how Richard Moon, who was a STEM-Talk guest on episode 26 (https://www.ihmc.us/stemtalk/episode-26/), played a significant role in her development. [00:26:14] Ken and Dawn reminisce on the practice of performing academic research in libraries. [00:28:20] Ken points out that despite Dawn’s extensive experience in human physiology with respect to diving, her doctoral work focused on cancer-related research. He asks her to talk about that seemingly odd combination. [00:34:10] Dawn talks about two papers that emerged from this research. One paper (https://www.researchgate.net/publication/223971943_Genes_with_Bimodal_Expression_Are_Robust_Diagnostic_Targets_that_Define_Distinct_Subtypes_of_Epithelial_Ovarian_Cancer_with_Different_Overall_Survival) addressed how genes with bimodal expression patterns not only define clinically relevant molecular subtypes of ovarian carcinoma, but also provide ideal targets for translation into the clinical laboratory. The other paper (https://www.researchgate.net/publication/43023522_Intratumor_Heterogeneity_and_Precision_of_Microarray-Based_Predictors_of_Breast_Cancer_Biology_and_Clinical_Outcome) looked at precise microarray-based predictions of tumor behavior in breast cancer patients. [00:39:00] Ken asks Dawn to recount the story of how the two of them met. [00:41:52] Ken asks Dawn to discuss the paper she co-wrote with Dom D’Agostino…

    Not rated yet
  • Episode 186: Mari Dezawa discusses her discovery of MUSE cells and the role of stem cells in regenerative medicine

    · 47 min

    Today we have Dr. Mari Dezawa, one of the world’s leaders in stem-cell research and regenerative medicine. Mari is a pioneer in this emerging field and is known worldwide for her discovery of MUSE cells, a unique type of stem cell with exciting clinical potential. MUSE is short for Multilineage-Differentiating Stress-Enduring Cells. The discovery of the MUSE cell in humans has many biological and medical implications, and the human body may have a greater regenerative potential than we might have ever imagined. In collaboration with major national and international institutions, Mari and her colleagues are promoting research on MUSE cell-based regenerative medicine for diseases without definitive treatments. She and her team are also exploring the differences in regenerative capacity between less and more complex animals from the viewpoint of the stem-cell system. Mari is a professor and chair of the Division of Stem Cell Biology and Histology at Tohoku University School of Medicine. She has published more than 200 papers and is particularly known for her 2010 paper on the mechanisms of MUSE cells. In 2018, she was appointed a fellow of the U.S. National Academy of Inventors and has been the recipient of numerous awards, including the Japanese Government’s Prize for the Commendation for Science and Technology. Show notes: [00:04:10] Ken opens the interview by mentioning that although Mari was born in Japan, her family moved to the U.S. when she was only eight months old. Ken asks if it is true that Mari finds it difficult to answer the question of where her hometown is. [00:05:23] Ken asks Mari how she handled moving so much as a child. [00:05:52] Ken mentions that Mari’s father was a researcher and asks when she became passionate about research and science. [00:06:58] Ken mentions that Mari attended the Chiba University School of Medicine and asks what inspired her to go to medical school. [00:07:19] Ken explains that after Mari earned her medical degree, she attended Chiba University Graduate School of Medicine for her Ph.D. Ken mentions that while Mari was initially a cardiology resident, she later decided to focus on clinical research and became a stem-cell researcher. Ken asks what led her to shift from cardiology to stem-cell research. [00:08:25] Ken explains that Mari is well-known for her research into the role of stem cells in regeneration and functional recovery of nerve and muscle cells. Ken asks how and when she first became interested in stem cells. [00:09:56] Ken asks Mari to give a brief overview of stem cells and their significance. [00:11:18] Ken mentions that Mari remained at Chiba University as a research associate after earning her Ph.D in 1995. She then took a position as an associate professor at Yokohama City University Graduate School of Medicine before accepting a position at Kyoto University Graduate School of Medicine as an associate professor in 2003. Ken explains that while at Kyoto, Mari developed methods to induce bone marrow stromal cells to generate neuro and skeletal muscle cells, which play a crucial role in tissue repair and regeneration and are widely studied for their potential to serve as therapeutic agents. Ken asks Mari to give a quick primer on the crucial role these cells play in tissue repair. [00:13:25] Ken explains that in 2003, a member of Mari’s technical staff at Kyoto asked her whether they should discard some cultured adult rat and human bone marrow mesenchymal stem cells (MSCs) after she had noticed several strange cell clusters. Ken asks Mari to share what happened next and how this set her on the path to the discovery of Multilineage-Differentiating Stress-Enduring Cells. [00:16:03] Ken asks Mari to elaborate on this story and explain how a mistake led to this incredible discovery. [00:20:48] Ken explains that in 2008 Mari became professor and chair of the Department of Stem Cell Biology and Histology at Tohoku University Graduate School of Medicine. Then in…

    Not rated yet
  • Episode 185: Andrew Koutnik discusses metabolic health, athletic performance and growing up with type-1 diabetes

    · 1 hr 31 min

    Today we have our good friend and colleague Dr. Andrew Koutnik on the show. Andrew is a research scientist who studies the influence of nutrition and metabolism on health, disease and performance. He specializes in Type 1 diabetes and works with a wide range of people to improve their metabolic health and athletic performance. Andrew is a visiting research scientist at IHMC and has worked with Harvard, Johns Hopkins, NASA, and the Department of Defense to develop evidence-based strategies for overcoming complex health challenges. He is a graduate of Florida State University and earned his Ph.D. in medical sciences at the University of South Florida, where he worked with another good friend of ours, Dr. Dominic D’Agostino, who has been a previous STEM-Talk guest. Show notes: [00:02:50] Dawn welcomes Andrew to the show and asks him about his website, andrewkoutnik.com (http://andrewkoutnik.com), the quote on the site’s homepage “Demystifying complex science to help you thrive in your health journey,” and the tagline “Challenging the status quo of metabolic health, human performance, and the management of type1 diabetes.” [00:05:31] Ken asks Andrew how old he was when he first learned he had Type 1 diabetes. [00:08:32] Dawn asks why Andrew believes his Type 1 diabetes is one of his life’s ultimate assets? [00:12:51] Ken mentions that Andrew grew up in Tallahassee and that despite suffering from childhood obesity, he was relatively athletic as a child. Ken asks Andrew to talk about his childhood. [00:14:20] Dawn asks Andrew to talk about the weight-loss journey he underwent as a teenager. [00:17:25] Dawn shifts gears to ask Andrew about how he got into science, mentioning that when he was younger, he never saw himself becoming a scientist. [00:20:19] Dawn asks if it is true that Andrew was the sort of kid who would constantly asked questions. [00:22:11] Dawn asks Andrew if it is true that after enrolling at Tallahassee Community College, it took him a while to decide on his major. [00:22:58] Ken asks Andrew to talk about the impact that his undergraduate anatomy and physiology class and professor had on his journey. [00:24:44] Ken mentions that after graduating from FSU, Andrew went to the University of South Florida where he worked with Dominic D’Agostino, who is both a previous STEM-Talk guest (https://www.ihmc.us/stemtalk/episode-153/) and a current colleague of Andrew’s. Ken asks Andrew how he met Dom. [00:27:46] Dawn asks Andrew how he came to work in Dom’s lab. [00:29:00] Dawn asks Andrew if his wife is still in touch with her former roommate, who connected Andrew and Dom. [00:29:21] Ken asks Andrew to touch on some of the research he did with Dom while he was pursuing his Ph.D. [00:31:49] Dawn shifts gears to talk about Andrew’s work in metabolic health and Type 1 diabetes. Dawn explains that a study published by the University of North Carolina found only 12 percent of Americans were metabolically healthy. Additionally, researchers from the Friedman School of Nutrition Science and Policy at Tufts University found in 2022 that only 6.8 percent of Americans had good cardiometabolic health. Dawn asks Andrew how he works with people who want to improve their metabolic health. [00:34:19] Ken asks Andrew for his thoughts on the sentiment that a ketogenic diet is hard to sustain. [00:36:55] Ken mentions that Andrew was part of a review that looked at carbohydrate restriction for diabetes (https://www.jci.org/articles/view/142246), which is a practice that had been in use since the 1700s. It fell out of favor once insulin was discovered in the 1920s. Ken goes on to explain that carbohydrate restrictive diets, like the ketogenic diet, have regained popularity for the treatment and management of diabetes, weight-loss and a range of other health issues such as migraines, cancer and depression. Ken asks Andrew to first explain the history of carb-restrictive diets as a treatment of diabetes. [00:39:43] Ken asks…

    Not rated yet
  • Episode 184: Ken and Dawn answer listener questions on AI, grip strength, ketamine, protein, digital twins, and more!

    · 44 min

    It’s time for another episode of Ask Me Anything. Dawn and Ken answer listener questions that range from generative AI to whether grip strength is a biomarker for longevity and the potential of ketamine as a treatment for depression. Dawn also gives a brief overview of work she is doing with the deep-sea technology company Deep. As a special treat at the end of today’s episode, Dawn plays a recording of the commencement speech that Ken recently gave at the University of West Florida. As the saying goes, you don’t want to miss it. Show notes: [00:02:18] Ken starts off the episode with a listener question about whether Dawn and Ken read print books or digital, the reason being that a listener recently came across an article that claimed digital screens are rewiring our brains. [00:05:32] A listener asks about a paper titled “Grip Strength An Indispensable Biomarker for Older Adults” (https://www.tandfonline.com/doi/full/10.2147/CIA.S194543) which claims that the ability to hang from a bar for 60 seconds for men, and 30 seconds for women, indicates that a person is likely to live longer. The paper claims that a decline in grip strength is associated with adverse health consequences, and the listener asks Ken what advice he has for developing and maintaining grip strength. [00:10:20] A listener asks a question inspired by our recent interview with Dr. Frank Butler (https://www.ihmc.us/stemtalk/episode-177/). The listener asks if Ken has heard about the FDA approved depression therapy, esketamine, which is a derivative of ketamine and is a long-standing therapy for depression. [00:12:37] A listener asks Ken about a 2023 paper in the journal Age and Aging titled “Higher Dietary Protein Intake is Associated with Sarcopenia in Older British Twins” (https://academic.oup.com/ageing/article/52/2/afad018/7036280) [00:16:13] A listener asks Ken about “Whisper,” which is a transcription product from OpenAI. The listener explains that OpenAI disclaims that Whisper should not be used in high-risk domains. However, according to a story by the Associated Press titled “Researchers Say an AI Powered Transcription Tool Used in Hospitals Invents Things No One Ever Said,” (https://apnews.com/article/ai-artificial-intelligence-health-business-90020cdf5fa16c79ca2e5b6c4c9bbb14) medical centers have already begun to use the tool to transcribe physician consultations. The listener explains that, according to the article, the use of Whisper in these contexts has led to numerous ‘hallucinations’ from the AI tool and the listener asks Ken what his thoughts are on how tools like Whisper should be integrated into various industries. [00:20:21] A listener asks for Ken’s thoughts on a series of articles by Kevin Roose in The New York Times claiming that there is no reason to learn how to code and program because very soon AI will take over all coding. Mr. Roose also asserts that the time is soon approaching when we need to have discussions on what rights to grant sentient AI. [00:21:57] A listener asks Ken if he concurs with a report from the National Academy of Medicine titled “Generative Artificial Intelligence in Health and Medicine – Opportunities and Responsibilities for Transformative Innovation,” (https://www.nejm.org/doi/abs/10.1056/NEJMsb2503956) which notes that large language models (LLMs) hold huge promise for patient care and healthcare system workflows, as well as risks. The listener asks if Ken agrees with the report’s claims that two areas in which we could see near term applications of LLMs are patient education and synthesis of information of electronic medical records. [00:23:35] As a follow up question, Ken is asked about the aforementioned report’s discussion of the “digital twin” concept. A digital twin is a computational representation of a patient or disease that could be used to speed up virtual experiments or subgroup analysis of investigational agents that carry risk for real patients. [00:26:26] A listener asks for Ken’s…

    Not rated yet
  • Episode 183: Michael Schmidt on the challenges of building a space-faring civilization

    · 1 hr 34 min

    Today we have the second installment of our interview with Dr. Michael A. Schmidt, the founder, CEO, and Chief Scientific Officer of Sovaris Aerospace, a company focused on assessments and solutions applied to humans in space and extreme environments on Earth. In today’s interview, we talk to Michael about NASA’s plans to send humans to Mars and build permanent colonies on the Moon and Mars. We also talk to Michael about his recent book, “Building a Space-Faring Civilization,” (https://www.amazon.com/Building-Space-Faring-Civilization-Renaissance-Performance-ebook/dp/B0DQLJPJ3K/ref=sr_1_1?crid=1O5ET9CV0JXU8&dib=eyJ2IjoiMSJ9.0EI3xz1uCG04hUyryPthWCUMqglncep2jV4fpTFwVC0.Uao1AAzHVFye77lsL378OcyrBJ6jz1n_YjU9go8Dwh0&dib_tag=se&keywords=Building+a+space+Michael+Schmidt&qid=1738853655&sprefix=building+a+space+michael+schmidt%2Caps%2C169&sr=8-1) which addresses the challenges of civilian spaceflight and the construction of space settlements. In part one of our interview, Episode 182 (https://www.ihmc.us/stemtalk/episode-182/), we talked with Michael about his pioneering work in the field of precision medicine and how he has used it to improve the cognitive and physical performance of astronauts as well as NBA, NFL players and Special Operations forces. In addition to his work with Sovaris, Michael also is a professor of aerospace medicine at the University of Central Florida College of Medicine, one of the few programs in the U.S. that offers a medical residency in aerospace medicine. Show notes: [00:03:00] Dawn picks up our interview from where we left off in part one, discussing the Human Research Program for Civilian Spaceflight. She goes on to mention that Chris Mason at Cornell University has a biobank of 1,500 samples across 22 astronauts and seven missions, and that these samples will lead to deeper insights on the effects of spaceflight on humans. Dawn switches gears to ask Michael about the cognitive and physical challenges of spaceflight over long duration missions. [00:13:03] Following up on the cognitive challenges of long duration spaceflight, Ken mentions that the hippocampus, the primary memory center of the brain, has a relatively low radiation threshold compared to other tissues in the brain. Ken asks Michael to touch on the vulnerability of specialized brain tissues to radiation, particularly in the context of a long duration spaceflight to Mars. [00:21:53] Ken mentions that it is understood that the APOE4/4 genotype is associated with impaired cognitive performance under certain circumstances and an elevated risk of dementia. While it is currently unknown whether APOE4/4 has any correlation of increased risk associated with cognitive impact resultant from environmental exposure due to spaceflight, Ken highlights the concern with sending APOE4/4-positive astronauts on long duration spaceflights without knowing the risks. [00:29:26] Ken notes the worsened cognitive impacts resultant from medical radiation, and while therapeutic radiation is different than radiation experienced by astronauts, these results give some indication of the effects astronauts might experience. [00:33:27] Dawn mentions that we recently had planetary scientist and director of NASA’s Haughton-Mars project, Pascal Lee, on the podcast (https://www.ihmc.us/stemtalk/episode-180/), who explained his view that since there are so many engineering and biological challenges with going to Mars, we should take a more measured approach to a Mars mission, perhaps even beginning with a roundtrip to Mars rather than landing on our first visit. Dawn asks Michael what his thoughts are on this approach. [00:37:29] Ken shifts the discussion to the subject of one of Mars’ moons, Phobos, and its potential role in a Mars mission. [00:40:30] Dawn pivots to talk about Michael’s Book “Building a Space-Faring Civilization: Advancing the Renaissance of Science, Medicine and Human Performance in Civilian Spaceflight.”…

    Not rated yet
  • Episode 182: Michael Schmidt on what precision medicine means to human spaceflight

    · 1 hr 15 min

    Today we have Dr. Michael A. Schmidt, the founder, CEO, and Chief Scientific Officer of Sovaris Aerospace, a company focused on assessments and solutions applied to humans in space and extreme environments on Earth. Michael is also a professor of aerospace medicine at the University of Central Florida College of Medicine, one of the few programs in the U.S. that offers a medical residency in aerospace medicine. Michael is known for his work pioneering the field of precision medicine. He uses molecular analytics, coupled with physiologic and behavioral assessments, to facilitate human performance and resilience on Earth as well as in the extreme environment of space. His work covers a spectrum from NASA, the NFL, the NBA, U.S. Olympic teams, Nike, SpaceX, Axiom Space, NASCAR, Special Operations, the Naval Submarine Medical Research Lab, the Mayo Clinic, and others. We had a long and fascinating conversation with Michael and decided to break the interview into two parts. This episode focuses on Michael’s background and the cognitive and physical challenges astronauts experience in spaceflight. We also dive into the many ways that precision medicine is facilitating human performance and resilience here on Earth. In part two of our conversation, Michael talks about his work with NASA and SpaceX on the challenges of civilian spaceflight and the future of Mars exploration, including the construction of permanent colonies on the Moon and Mars. You won’t want to miss that conversation. Show notes: [00:03:59] Dawn opens our interview mentioning that Michael grew up in Minnesota in a small farming community, asking if it’s true that he sometimes had to do chores in 20- to 30-degree weather. [00:06:50] Dawn asks if it is true that Michael fell in love with science at a young age, even building telescopes at the age of 11. [00:08:00] Dawn asks Michael what it was that led him to become so fascinated with space specifically. [00:08:58] Dawn asks if Michael ever thought about becoming an astronaut. [00:10:09] Ken asks if it is true that Michael was a big reader as a child. [00:11:21] Dawn asks Michael to talk about his childhood athletic interests. [00:11:55] Dawn asks how it was that a high school quarterback from a small town in Minnesota ended up at university in the United Kingdom. [00:13:38] Ken asks Michael what years he worked at NASA Ames Research Center. [00:14:51] Ken mentions that when Michael was at NASA Ames, he did work collecting molecular and physiologic assessments of humans using NASA’s 20-G centrifuge. Ken asks Michael to talk about the centrifuge and how he used it in his studies of hypergravity. [00:17:49] Ken comments on the fact that pieces of equipment like NASA’s 20-G centrifuge are a precious scientific resource, and when they cease functioning, unfortunately, they are unlikely to be replaced. [00:19:40] Ken and Michael discuss the fact that microgravity, despite being one of the most pressing effects on astronaut health, is the one of the least addressed problems in human spaceflight. [00:21:48] Ken explains that Michael is the founder, CEO and Chief Scientific Officer of a company called Sovaris Aerospace, which is focused on assessments and solutions applied to humans in space and extreme environments on Earth. Ken asks Michael where the idea came from to found this company. [00:24:35] Dawn explains that since the human genome was first sequenced, there has been an acceleration of genome-based technologies that have made it possible to consider a person’s genetic makeup, both in healthcare and optimizing performance. Dawn asks Michael to talk about the work he does applying genomics to human spaceflight. [00:28:52] Dawn asks about Michael’s direction of the molecular profiling and precision medicine efforts for the Golden State Warriors during their record-breaking 73-9 season [00:32:57] Dawn mentions that Michael published a review in the journal Metabolomics in 2013…

    Not rated yet
  • Episode 181: Ken Forbus talks about AI and his development of the Structure Mapping Engine

    · 1 hr 25 min

    Our guest today is Dr. Ken Forbus, the Walter P. Murphy Professor of Computer Science and a Professor of Education at Northwestern University. Joining Dr. Ken Ford to co-host today’s interview is Dr. James Allen, who was IHMC’s associate director until he retired a few years ago. James is a founding fellow of the American Association for Artificial Intelligence and a perfect fit for today’s discussion with Dr. Forbus, who, like James, is an AI pioneer. Back in 2022, James was named a fellow by the Association for Computational Linguistics, an organization that studies computational language processing, another field he helped pioneer. Dr. Forbus also is a Fellow of the Association for the Advancement of Artificial Intelligence and was the inaugural winner of the Herbet A. Simon Prize for Advances in Cognitive Systems. He is well-known for his development of the Structure Mapping Engine. In artificial intelligence and cognitive science, the Structure Mapping Engine is a computer simulation of analogy and similarity comparisons that helped pave the way for computers to reason more like humans. Show Notes: [00:03:07] Ken opens the interview with Dr. Forbus by asking if it is true that he had an unusual hobby for a nerdy kid growing up. [00:04:18] James mentions that Dr. Forbus’ family moved often when he was younger and asks how that affected him. [00:05:18] Ken mentions that when Dr. Forbus was in high school, he filled his free time reading about psychology and cognition before eventually coming across some articles on AI. Ken asks Dr. Forbus to talk about this experience and what happened next. [00:07:49] James asks Dr. Forbus if he remembers the first computer he owned. [00:09:17] Ken asks Dr. Forbus if there was anything, other than its reputation, that led him to attend MIT. [00:10:09] James mentions that for the past few decades, Dr. Forbus has been working on developing “human like” AI systems. While much of AI research and development has been focused on meeting the standard of the Turing test, James asks Dr. Forbus why he is not a fan of the Turing test. [00:12:24] Ken mentions that Dr. Forbus received his Ph.D. from MIT in 1984, the same year that Apple released the first Macintosh, which was rolled out with a famous Super Bowl ad. This computer was the first successful mouse driven personal computer with a graphical interface. Ken asks Dr. Forbus what he remembers about that ad, and what his reaction to it was at the time. [00:13:22] James mentions that 1984 was also the year that Dr. Forbus made his first splash in the AI world with his paper on qualitative process theory (https://scholar.google.com/citations?view_op=view_citation&hl=en&user=IdRYT-8AAAAJ&citation_for_view=IdRYT-8AAAAJ:u5HHmVD_uO8C). James goes on to explain that at the time, qualitative reasoning regarding quantities was a major problem for AI. In his paper, Dr. Forbus proposed qualitative process theory as a representational framework for common sense physical reasoning, arguing that understanding common sense physical reasoning first required understanding of processes and their effects and limits. James asks Dr. Forbus to give an overview of this paper and its significance. [00:18:10] Ken asks Dr. Forbus how it was that he ended up marrying one of his collaborators on the Structure Mapping Engine project, Dedre Gentner. [00:19:14] James explains that Dedre’s Structure Mapping Theory (https://en.wikipedia.org/wiki/Dedre_Gentner) explains how people understand and reason about relationships between different situations, which is central to human cognition. James asks Dr. Forbus how Dedre’s theory was foundational for the Structure Mapping Engine (SME). [00:25:19] Ken mentions how SME has gone through a number of changes and improvements over the years, as documented in Dr. Forbus’ 2016 paper “Extending SME to handle large scale cognitive modeling.” (https://onlinelibrary.wiley.com/doi/10.1111/cogs.12377) Ken asks, as a cognitive…

    Not rated yet